The study confirmed that Afqlir has equivalent efficacy and comparable safety to its reference medicine, Eylea.

Following US approval in May this year, South Korea’s Samsung Bioepis and US biotech Biogen have now won approval from the ...

Two papers published in Journal of Orthopaedic Research Spine show the promise of PP353 through preclinical development and ...

(RTTNews) - Samsung Bioepis Co., Ltd. and Biogen Inc. (BIIB) Monday announced that the European Commission (EC) has approved Opuviz, a biosimilar to Regeneron Pharmaceuticals' Aflibercept.

Weight loss Tiredness Swollen ankles from a build-up of fluid (oedema) Chest pain and coughing up blood - although these are usually signs of another condition, such as chest infection or possibly ...

It is known as angioedema, a (typically obscure) technical term to describe its two salient features: swelling (oedema) due to the outpouring of fluid from the blood vessels (angio) into the ...

INCHEON, South Korea and CAMBRIDGE, MA, USA I November 18, 2024 I Samsung Bioepis Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the European ...

A Samoan man whose leg swelled so large he couldn't lift it to walk is having life-changing surgery this week that will allow him to wear shoes for the first time in more than a decade. Amy Williams ...

Emmecell announced positive Phase 1 extension study results for EO2002, a nonsurgical cell therapy for corneal edema. The ...